These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 21741639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D, Schmitt C, Wong JB.
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
    Rubenstein JH, Inadomi JM, Brill JV, Eisen GM.
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
    [Abstract] [Full Text] [Related]

  • 5. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
    Das A, Wells C, Kim HJ, Fleischer DE, Crowell MD, Sharma VK.
    Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
    [Abstract] [Full Text] [Related]

  • 6. Screening and surveillance of Barrett's esophagus.
    Regula J.
    Dig Dis; 2009 May; 27(1):54-7. PubMed ID: 19439961
    [Abstract] [Full Text] [Related]

  • 7. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
    Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G.
    Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic screening for gastric cancer.
    Dan YY, So JB, Yeoh KG.
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P, Sidorenko EI.
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [Abstract] [Full Text] [Related]

  • 11. The rationale for screening and surveillance of Barrett's metaplasia.
    Wani S, Sharma P.
    Best Pract Res Clin Gastroenterol; 2006 Mar; 20(5):829-42. PubMed ID: 16997164
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of screening a population with chronic gastroesophageal reflux.
    Nietert PJ, Silverstein MD, Mokhashi MS, Kim CY, Glenn TF, Marsi VA, Hawes RH, Wallace MB.
    Gastrointest Endosc; 2003 Mar; 57(3):311-8. PubMed ID: 12612508
    [Abstract] [Full Text] [Related]

  • 13. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F, van Olphen S, Steyerberg EW, Sikkema M, Spaander MC, Looman CW, Kuipers EJ, Siersema PD, Bruno MJ, de Bekker-Grob EW, ProBar-study group.
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [Abstract] [Full Text] [Related]

  • 14. [Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?].
    Remes-Troche JM, Ramírez-Arias JF, Gómez-Escudero O, Valdovinos-Andraca F, Vargas-Vorácková F.
    Rev Gastroenterol Mex; 2006 Jun; 71(1):46-54. PubMed ID: 17061478
    [Abstract] [Full Text] [Related]

  • 15. Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.
    Inadomi JM.
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):51-63. PubMed ID: 25743456
    [Abstract] [Full Text] [Related]

  • 16. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
    Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N.
    Ann Intern Med; 2003 Feb 04; 138(3):176-86. PubMed ID: 12558356
    [Abstract] [Full Text] [Related]

  • 17. Barrett's esophagus surveillance: When, how often, does it work?
    Katona BW, Falk GW.
    Gastrointest Endosc Clin N Am; 2011 Jan 04; 21(1):9-24. PubMed ID: 21112494
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
    Gerson LB, Groeneveld PW, Triadafilopoulos G.
    Clin Gastroenterol Hepatol; 2004 Oct 04; 2(10):868-79. PubMed ID: 15476150
    [Abstract] [Full Text] [Related]

  • 19. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?
    Soni A, Sampliner RE, Sonnenberg A.
    Am J Gastroenterol; 2000 Aug 04; 95(8):2086-93. PubMed ID: 10950062
    [Abstract] [Full Text] [Related]

  • 20. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D, Kemp JA, Arora S, Wong JB.
    Am J Gastroenterol; 1994 May 04; 89(5):670-80. PubMed ID: 8172136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.